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transgenic miceMethods: Wild-type and transgenic mice were used as the control and study groups, respec-
tively. Body weight measurement, radiographic analysis, and histological analysis of the mice
were carried out to describe differences between the wild-type and transgenic mice at
different ages. Cartilage metabolism studies were also carried out, including an MTT assay
of cellular proliferation and nitric oxide and glycosaminoglycan assays. Allelic expression levels
of the mutant A allele and the normal G allele were established by TaqMan assay. Cytokine and
protease gene expression were measured.
Results: Transgenic mice had a lower mean body weight, a deformed skeletal structure, and
abnormal cartilage histomorphology. Chondrocyte proliferation was significantly compromised
and this was linked to significantly higher NO secretion and less soluble glycosaminoglycan for-
mation. TNF-a and IL-1b gene expression was significantly upregulated, while MMP-13 gene
expression was significantly downregulated.
Conclusion: The mutant G1170S Col2a1 gene in mice clearly alters the transgenic murine
phenotype and cartilage matrix homeostasis.
Copyright ª 2013, Elsevier Taiwan LLC & Formosan Medical Association. All rights reserved.Introduction
The Col2a1 gene encodes type II collagen, and mutation of
this gene may cause type II collagenopathy. Type II collagen
is by far the most abundant collagen in articular cartilage.1
Articular cartilage provides a nearly frictionless surface and
acts as a load absorber during movement. Type II colla-
genopathy prompts degradation of articular cartilage,
which consequently results in arthropathies. Type II
collagen also comprises most of the organic part of the
physis.2,3 During endochondral osteogenesis, long bone
growth arises from cartilage, which is replaced by bone in
the hypertrophic zone of the physis.4 Type II collagenop-
athy disturbs the process of bone growth and this in turn
causes abnormal skeletal development.
In cartilage, chondrocytes are surrounded by extracel-
lular matrix (ECM).5 The formation of type II collagen and
glycosaminoglycan (GAG) favors ECM biosynthesis. ECM
maintenance requires a balance between its biosynthesis
and degradation, and this is regulated by chondrocytes. A
number of potential catabolic factors may interact with
chondrocytes and induce signaling cascades that activate
gene transcription and post-transcriptional modifications.6
Proinflammatory cytokines, including tumor necrosis fac-
tors (TNFs) and interleukin (ILs), collagen-degrading matrix
metalloproteinases (MMPs), aggrecanases (ADAMTSs),
excessive mechanical stress, reactive oxygen species (ROS),
and degraded ECM particles are all catabolic factors that
promote ECM degradation. In this context, the modulating
factors secreted from chondrocytes are regulated if the
structural components of the ECM change either towards
biosynthesis or towards breakdown.
Mutation in the human Col2a1 gene has been associated
with many different skeletal abnormality patterns. The
clinical phenotypes range from perinatal lethality due to
achondrogenesis II and hypochondrogenesis, to relatively
mild symptoms due to late-onset arthropathy, such as
arthropathy with epiphyseal dysplasia, osteochon-
drodysplasia, and precocious osteoarthropathy.4,7 In animal
models, several forms of Col2a1 point mutation result in
various abnormal murine phenotypes.8,9 In these studies,
ultrastructural analyses revealed reduced collagen density,derangement of type II collagen fibrils, and the presence of
dilated Golgi bodies. In parallel, radiographic studies
showed shortened limbs and cleft palates, while histologi-
cal studies have demonstrated disorganized growth plates.
The G1170S point mutation of human Col2a1 is related to
various hip disorders, including osteonecrosis of the
femoral head (ONFH), LeggeCalve´ePerthes disease, and
precocious osteoarthritis of the hip.10e13 A new type II
collagenopathy has recently been identified by histological
and ultrastructural studies of cartilage of the human
femoral head harvested during total hip arthroplasty in
patients with a mutated gene.14 However, no animal model
with this Col2a1 mutation has been reported to date.
There is a high degree of similarity between murine and
human genomic sequences and this is supported by the fact
that the numbers of protein-coding genes (w25,000 in
mouse and w24,200 in human) are also similar; therefore,
mice are regarded as an ideal animal model for studying
human genetic disorders. The human and murine Col2a1
amino acid sequences are highly similar. BLAST sequence
comparison reveals 95% identity between the proteins
encode by human COL2A1 (NCBI accession number
NP_001835.3) and murine Col2a1 (NP_112440.2). The
glycine residue at position 1170 and its neighboring amino
acid are the same in both species. We used wild-type (WT)
and transgenic (TG) G1170S Col2a1 mice from the National
Health Research Institutes of Taiwan as experimental ani-
mals. The purpose of the study was to elucidate whether
the mutated Col2a1 gene alters the murine phenotype and
cartilage matrix homeostasis.Methods
Introduction of a point mutation in Col2a1
The animal handling protocol was approved by the institu-
tional committee of the National Health Research In-
stitutes, Taiwan. To obtain a fragment of the Col2a1 gene
that contained serine at amino acid position 1170, a murine
Col2a1 cDNA clone obtained from a pCMV-SPORT6.1 library
of mammalian genes (MGC; clone list accession number
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MA, USA) and used for PCR mutagenesis. Sense and anti-
sense mutagenesis primers designed from the sequence of
exon 48 with mutated nucleotides (in boldface type) were
used, namely 50-ACC TGG CCC TGT TAG TCC CTC TGG
CAA AG-30 and 50-CTT TGC CAG AGG GAC TAA CAG GGC CAG
GT-30. Using the methods described in the QuickChange
site-directed mutagenesis kit (Stratagene, La Jolla, CA,
USA), a G/A single-base point mutation at position 3425 of
the murine Col2a1 cDNA sequence, which changes GGT
(glycine) to AGT (serine), was introduced into the MGC
clone. After verification of the mutation by sequencing, the
PCR product was digested with EcoRI and Xbal, and the 4.8-
kb mutant Col2a1 cDNA fragment was subcloned into a
pBlueScriptII KS() vector (Stratagene), and ligated to an
SV40 polyA signal and two tandem units of the 1.2-kb
insulator of the chicken globin gene.15 The resulting
construct was ligated to the 6.02-kb NotIeXboI fragment of
a Col2a1-Cre gene construct (pCol2.IRES.cre.pA)16 consist-
ing of a 3-kb sequence of the Col2a1 promoter region (exon
1 with a mutated initiation codon) and a 3.02-kb fragment
of the first intron ligated to a splice acceptor sequence. The
final 16.6-kb plasmid construct (pCol2A1-Ins-pA-G1170S)
was digested with BssHII and the resulting 13.8-kb fragment
was purified. This was microinjected into pronuclei of mu-
rine embryos from the inbred C57BL/6 mice strain.
Identification of transgenic mice
Transgenic mice were identified by PCR analysis of genomic
DNA from the tail. The primers used for PCR were sense
primer 3F-2 (50-CTGCACCATCTCTTCCAG-30) for exon40 and
antisense primer 4R (50-CAA AGG TGT TCG AGG AGA C-30) for
exon 43 (Fig. 1A). Thepredicted PCRproduct size is 371 bp for
the transgene and 950 bp for the endogenous Col2a1 tem-
plate. Therefore, the products were easily distinguished
after separation by agarose gel electrophoresis (Fig. 1B). The
transgene copy number was determined by Southern blot-
ting. In brief, extracted DNA was digested with EcoRI, sepa-
rated by agarose gel electrophoresis, transferred to a nylon
membrane, and probed with a [32P]dCTP-labeled 1.2-kb
insulator sequence complementary to the end part of the
transgene. The expected DNA fragment size is 4.4 b. Het-
erozygous transgenic progeny for this study were obtained
from crosses between twoWT females and themale founder.
The WT and TG strains in both cases were C57BL/6 mice. All
mice were bred in a specific pathogen-free facility.
Morphological measurements and radiographic
imaging
Eight WT mice and four TG mice were used for morpho-
logical and radiographic studies. The body weight of each
mouse was recorded from 13 to 31 days after birth. At the
age of 12 weeks, the mice were sacrificed and radiographs
were obtained.
Histology of femoral head cartilage
Femoral heads were harvested from WT and TG mice at the
ages of 2 months and 10 months. Hematoxylin and eosinstaining was performed. The arrangement and morphology
of chondrocytes and their zonal distribution in articular
cartilage were compared.
Chondrocyte culture
Mice of 4e6 days of age were sacrificed by CO2 asphyxi-
ation. Cartilage pieces were taken from the knees of WT
and TG mice and were minced and washed in sterile PBS
twice, then treated with 0.2% collagenase and incubated
in 5% CO2 at 37
C. After complete digestion, the chon-
drocytes were collected and seeded in Dulbecco’s modi-
fied Eagle’s medium (DMEM) with 10% fetal calf serum
(FCS) in 10-mm dishes and allowed to grow to confluence.
Chondrocytes in passage 2 were used as cells for spec-
trophotometric assays. The phenotype of the cultured
chondrocytes was verified by alcian blue straining, which
specifically stains GAG.
MTT assay
ForMTTassays, 6250 chondrocytes/wellwere introduced into
96-well microtiter plates for cell culture. At different time
points (Days1,4,7, and14), themitochondrial activityof cells
was determined by colorimetric assay of the conversion of 3-
(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide
(MTT; Sigma, St. Louis, MO, USA) to insoluble formazan. At
each time point, a sample of cell supernatant was removed
25 mL of 2.5mg/mLMTTsolution was added to each well. The
wells were incubated at 37 C for 3.5 hours to allow formazan
crystals to form. The supernatantwas removed and 100mL of
0.04 N HCl in ethanol was added to each well and mixed
thoroughly to dissolve the dark blue crystals. After a few
minutes at room temperature to ensure that all crystals were
dissolved, the plates were read on an ELISA plate reader
(Spectra max 340, Molecular Devices, Sunnyvale, CA, USA) at
570 nm.
NO assay (Griess reaction)
For NO assays, 6250 chondrocytes/well were introduced
into 96-well microtiter plates for cell culture. At different
time points (Days 1, 4, 7, and 14), 20 mL of medium from
each well was transferred to another 96-well microtiter
plate and 10 ml of 0.1% sulfanilamide solution and 10 ml of
0.1% N-1-naphthyl-ethylenediamine dihydrochloride were
added to each well. After incubation for 10 minutes in the
absence of light, a purple color developed. The absorbance
of the converted dye was measured at 550 nm within 30
minutes using an ELISA plate reader.
GAG assay
For GAG assays, 6250 chondrocytes/well were introduced
into 96-well microtiter plates for cell culture. At different
time points (Days 1, 4, 7, and 14), 20 mL of medium from
each well was transferred to another 96-well microtiter
plate and 125 mL of dimethylmethylene blue solution was
added to each well. The absorbance of the converted dye
was measured at 525 nm using an ELISA plate reader.
Figure 1 Transgene construct and genotyping. (A) Transgene construct. The 16.6-kb mutant construct consists of the pro-
moter region of the Col2a1 gene (mCol2a1 Promoter); a Col2a1 first intron (Intron 1) that directs chondrocyte-specific
expression of the transgene murine Col2a1 coding sequence (mCol2a1 CDs); an SV40 polyA signal (SV40 polyA); and two
tandem units of the insulator of the chicken b-globin gene (Insulator). The function of the insulator is to overcome any po-
sitional effects with respect to transgene expression. The BssHII sites were used to excise the 13.8-kb insert for pronucleus
microinjection. Sense primer 3F-2 and antisense primer 4R targeting Col2a1 exons 40 and 43 were used for genotyping. The
position of the G / A point mutation in exon 48, which changes Gly to Ser at amino acid 1170, is shown by a red line. (B)
Genotyping. The predicted size of the PCR products differs between the genomic template (950 bp) and the transgene
template (371 bp). PCR genotyping was able to identify lanes 4, 6, and 8 as TG mice. The other lanes were recognized as WT
mice. Laneþ, transgene template. Lanee, genomic template.
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Pieces of cartilage were dissected from the knee joints of
4-day-old WT and TG mice and were snap-frozen in liquid
nitrogen and homogenized. Total RNA was isolated using
Trizol reagent (Life Technologies, Carlsbad, CA, USA) ac-
cording to the manufacturer’s instructions. TaqMan assays
were carried out using a two-step RT-PCR protocol and a
high-capacity cDNA reverse transcription kit (Applied Bio-
systems, Life Technologies, Grand Island, New York, USA).
The sequences for the primers and allele-specific probes
ware as follows: TaqMan sense primer, 50-TGG TCC TTC
TGG CCC TAG AG-30; TaqMan antisense primer, 50-GGA TTCCAT TAG AGC CAT CTT TGC-30; WT allele-specific G probe,
FAM-50-CCC TGT TGGT CCC TC-30; and mutant allele-
specific A probe, VIC-50-CCC TGT TAG TCC CTC-30. PCR
amplification was carried out on an ABI 7000 system
(Applied Biosystems) at 95 C for 10 min followed by 40
cycles of 95 C for 15 seconds and 60 C for 1 minute. The
b-actin gene was amplified as an endogenous control to
standardize the sample loadings. Data analysis was per-
formed using an ABI Prism 7000 instrument (Applied Bio-
systems) set to universal RT-PCR parameters. Allelic
expression was compared for the normal G allele in WT
cells (WT-G) and in transgenic cells (TG-G) and the mutant
A allele in transgenic cells (TG-A).
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Quantitative real-time PCR analysis was used to examine the
expression level of various proinflammatory factors (TNF-a,
IL-1b, and iNOS) and of various matrix-degrading enzymes
(MMP-3, MMP-9, MMP-13, ADAMTS-4, and ADAMTS-5). Total
RNA was isolated from dissected knee-joint cartilage pieces
from4-day-oldWTandTGmice, and cDNAwas synthesized as
described in the previous section. The primer sequences are
shown in Table 1. Thermocycling and data analysis were
performed using an ABI Prism 7000 instrument. Four inde-
pendent experiments were carried out for each sample for
both the TaqMan allelic discrimination assay and quantita-
tive real-timePCRanalysis. Dataobtained for the target gene
were normalized against the housekeeping gene b-actin for
each group. DCt and DDCt values were calculated according
toDCtZDCttarget geneDCtb-actin andDDCtZmeanDCtstudy
group  mean DCtcontrol group. The expression ratio for target
genes in the study group relative to that in the control group
was quantified using the 2eDDCt approach.
Statistics
All data were analyzed using SPSS Statistics 17.0 (IBM, In-
ternational Business Machines Corp., Armonk, New York,
USA). Data are expressed as mean  SD. One-way analysis
of variance (ANOVA) followed by a least squares difference
(LSD) post hoc test was applied for three-group comparison
of TaqMan allelic discrimination data. The Student t test
was used to compare data for the other assays. A p value of
<0.05 was considered statistically significant.
Results
Morphological measurements and radiographic
imaging
Mean body weight was lower for TG than for WT mice at all
time pints, but none of the differences were significantTable 1 Gene primers used for quantitative real-time PCR ana
Gene Primers
TNF-a Forward 50-CCAGAC
Reverse 50-CACTTG
IL-1b Forward 50-CAACAA
Reverse 50-CACAGG
iNOS Forward 50-AACATC
Reverse 50-CGTACC
MMP-3 Forward 50-AATACT
Reverse 50-AAGTAG
MMP-9 Forward 50-GTGTCT
Reverse 50-AGATGT
MMP-13 Forward 50-CTTGTG
Reverse 50-ACTGTG
ADAMTS-4 Forward 50-GACTTC
Reverse 50-ACAATA
ADAMTS-5 Forward 50-TGAGCC
Reverse 50-TCCAAA
b-Actin Forward 50-CCATCA
Reverse 50-CTTCTG(Fig. 2A). The extent of spinal kypholordosis was greater in
TG than in WT mice. The vertebral body was shorter and
broader in TG than in WT mice. Furthermore, the contour
of the occipital skull was more sharply angled in TG than in
WT mice (Fig. 2B,C). There was no obvious radiographic
evidence of osteonecrosis or osteoarthritis in the hetero-
zygous TG mice.
Cartilage histology
At the age of 2 months, there was a larger calcified zone
present in the femoral head cartilage of TG mice compared
to WT mice (Fig. 3A). In 10-month-old TG mice, the gross
articular cartilage thickness was less than that in WT mice
of the same age; furthermore, the chondrocyte density was
lower in these TG mice compared to their WT counterparts.
Microscopically, chondrocyte morphology in 10-month-old
TG mice was different and more disoriented compared to
that in WT mice of the same age (Fig. 3B).
MTT assay of chondrocytes
The presence of Col2a1 G1170S in TG chondrocytes
affected their viability as measured by MTT assay when
compared to WT chondrocytes (Fig. 4A).
NO assay
The presence of Col2a1 G1170S in TG chondrocytes
affected NO synthesis as measured by NO assay. The
amount of NO associated with chondrocytes was signifi-
cantly higher for TG than for WT mice on Days 1 and 14
(Fig. 4B).
GAG assay
The presence of Col2a1 G1170S in TG chondrocytes
affected their soluble GAG production. The amount oflysis.
Product size (bp)
CCTCACACTCAGA-30 79
GTGGTTTGCTACGA-30
GTGATATTCTCCATG-30 103
ACAGGTATAGATTC-30
AGGTCGGCCATCA-30 88
GGATGAGCTGTGA-30
GGAGGTTTGATGAGA-30 127
AGAAACCCAAATGCT-30
GGAGATTCGACTTG-30 102
CGTGTGAGTTCCAG-30
TTTGCAGAGCACTA-30 89
GAGGTCACTGTAGA-30
AATGTTCCTCAGGC-30 138
CTTGCCACCGTTCC-30
AATAATGCCGTCAC-30 100
GGTTACGGATGGGA-30
TGAAGTGTGACGTTGA-30 104
CATCCTGTCAGCAATG-30
Figure 2 Growth curve of and skeletal changes in the transgenic mice. (A) Growth curve chart. Solid triangles and squares denote
the mean body weight for WT and TG mice, respectively. Only positive error bars for WT mice and negative error bars for TG mice
are shown to avoid overlap of negative WT and positive TG error bars at the same time point. Mean body weight was greater for the
eight WT mice than for the four TG mice at all time points but the difference was not significant over the time period measured. (B)
Radiographic lateral view of the thoracolumbar spine. TG mice had more significant kyphosis along the thoracolumbar spine and
broader and shorter vertebral bodies than the WT mice. (C) Radiographic lateral view of the skull and upper spine. TG mice showed
more significantly sharp-angled contouring of the occipital skull (right curved arrow) than WT mice (left curved arrow). More
significant lordosis of the upper spine in TG than in WT mice is also evident.
Figure 3 Histological studies of murine femoral heads. (A) Histological analysis of the femoral head at age 2 months (100). The
calcified zone (double-headed arrows) of the articular cartilage is located beneath the tidemark (bold arrows). The proportion of
the calcified zone in the whole cartilage layer is larger for TG than for WT mice. (B) Histological analysis of femoral head cartilage
at age 10 months (100). The articular cartilage thickness is less in TG mice, and chondrocyte density and size (arrows) are also less
in TG mice. The discrimination between different zones is more obscure in TG mice. The stratified and columnar patterns of
chondrocyte arrangement in superficial and middle zones are disoriented, and irregular arrangement of chondrocytes is evident in
TG mice.
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Figure 4 MTT, NO and GAG assays. (A) MTT assay of chondrocyte proliferation. Data are shown as mean  SD. N Z 8 for each
group on Days 1 and 4; NZ 7 for each group on Day 7; NZ 6 for each group on Day 14. *A p value of <0.05 is considered significant.
Chondrocyte proliferation was significantly lower in the TG group than in the WT group on Day 4 (p Z 0.01), on Day 7 (p Z 0.03),
and on Day 14 (pZ 0.002). (B) NO assay to quantify ROS. Data are shown as mean  SD. NZ 8 for each group on Days 1, 4, 7, and
14. * A p value of <0.05 is considered significant. The level of NO released by chondrocytes was significantly higher in TG than in WT
mice on Day 1 (pZ 0.001) and Day 14 (pZ 0.04). (C) GAG assay to quantify GAG production. Data are shown as mean  SD. NZ 8
for each group on Days 1, 4, 7, and 14. * A p value of <0.05 is considered significant. The level of GAG produced by chondrocytes
was significantly lower in TG than in WT mice for all four time points (pZ 0.033, p < 0.001, pZ 0.001, pZ 0.006, respectively).
Col2a1 mutation alters murine phenotype and cartilage matrix homeostasis 809soluble GAG in culture medium was significantly lower for
TG than for WT chondrocytes at all four time points
(Fig. 4C).
Allele-specific Col2a1 mRNA expression
The mean DCt value for WT-G, TG-A, and TG-G alleles was
1.62, e1.55, and 0.33, respectively. For WT-G versus
TG-G and TG-A versus TG-G the difference in DCt is sig-
nificant (both p < 0.001). However, the DCt difference
between TG-A and WT-G is not significant (p Z 0.54). The
allelic expression ratio was 0.95 for TG-A relative to WT-G,
0.41 for TG-G relative to WT-G, and 2.33 for TG-A relative
to TG-G (Fig. 5A).
Transcriptional profiles of proinflammatory factors,
collagen-degrading enzymes, and aggrecanases
Mean TNF-a mRNA expression in TG mice was 1.46 times
that in WT mice and the difference in DCt between the
groups was significant (p < 0.001). Mean IL-1b mRNA
expression in TG mice was 1.77 times that in WT mice and
the difference in DCt between the groups was significant
(p Z 0.012). There was no significant difference in mRNA
expression levels of iNOS (pZ 0.13), MMP-3 (pZ 0.82), and
MMP-9 (p Z 0.72) between TG and WT mice. Mean MMP-13
mRNA expression in TG mice was 0.85 times that in WT mice
and the difference in DCt between the groups was signifi-
cant (p Z 0.04). There were no significant differences in
ADAMTS-4 (p Z 0.40) and ADAMTS-5 (p Z 0.39) mRNAexpression between WT and TG mice. These results indicate
that mRNA expression of TNF-a and IL-1b was significantly
upregulated, while mRNA expression of MMP-13 was
significantly downregulated in TG compared to WT mice
(Fig. 5B,C).
Discussion
Phenotypic studies of mice carrying various Col2a1 muta-
tions have revealed alterations in the cartilage matrix, re-
ductions in the density and arrangement of type II collagen
fibrils, the presence of dilated Golgi bodies, disorganization
of growth plates, the presence of shortened limbs and cleft
palates, and a proportional reduction in body size.9,17e19
Radiographic analysis of TG mice carrying the Col2a1
Arg519Cys mutant revealed primary osteoarthritis and
osteochondrodysplasia, which is similar to the skeletal ab-
normalities found in humans with the same mutation.20 In
our study, we observed gross differences between WT and
TG mice that affected their growth and led to visible
changes on radiographic images. Mean body weight was
lower for TG mice and radiographic analysis demonstrated
an increased kypholordotic spinal curve and shorter and
broader vertebral bodies. These changes are similar to
radiographic characteristics associated with human osteo-
chondrodysplasia, which is known to occur for several
Col2a1 mutations.
Histological analysis of samples from our TG mice
revealed an increased calcified zone in younger TG mice, in
accordance with a histological study of humans carrying
Figure 5 Gene expression levels. (A) Allele-specific Col2a1mRNA expression. WT-G, normal Col2a1 G-allele expression in WT mice;
TG-G, normal Col2a1 G-allele expression in TG mice; TG-A, mutant Col2a1 A-allele expression in TG mice. Data are shown as the DCt
value (mean  SD, N Z 4). *A p value of <0.05 is considered significant. A lower DCt value indicates greater genetic expression.
Significant DCt differences were found for TG-G versus WT-G and for TG-A versus TG-G (both p < 0.001). No significant DCt difference
was detected between TG-A and WT-G (pZ 0.54). The allelic expression ratio for the study group relative to the control group was
calculated according to the 2eDDCT method. Allelic expression ratios were 0.95 for TG-A relative to WT-G, 0.41 for TG-G relative to
WT-G, and 2.33 for TG-A relative to TG-G. The mutant A allele apparently replaces the normal G allele and is dominant in TG mice.
(B,C) Transcriptional profiles of various proinflammatory factors, various collagen-degrading enzymes, and various aggrecanases.
Data are shown as the DCt value (mean  SD, N Z 4). * A p value of <0.05 is considered significant. A lower DCt value indicates
greater genetic expression. The genetic expression ratio for the TG group relative to the WT group was calculated using the 2eDDCt
method if a significant difference in DCt existed between the groups. mRNA expression levels of TNF-a and IL-1b were significantly
upregulated in TG mice. The mRNA expression level of MMP-13 was significantly downregulated in TG mice. Genetic expression ratios
for TNF-a, IL-1b, and MMP-13 in TG mice relative to those in WT mice were 1.46, 1.77, and 0.85, respectively.
810 R.-C. Yang et al.the same Col2a1 point mutation.14 Microscopic alterations
in femoral head cartilage might cause changes in bulk
mechanic properties and even diminish the ability to
tolerate stress, making femoral head cartilage more
vulnerable to stress during daily activity. For older TG
mice, histological analysis identified thinner articular
cartilage, a lower chondrocyte density, changes in chon-
drocyte morphology, and irregularities in chondrocyte
arrangement, all of which are associated with cellular
degeneration. This might partly explain the presence of
precocious osteoarthritic hips in humans carrying the
Col2a1 G1170S mutation.14 We found that expression of the
normal G allele was significantly downregulated in our
heterozygous TG mice, and the mutant A allele seemed to
have replaced the normal G allele as the dominant allele
responsible for type II collagen production. In the tran-
scription process, the Col2a1 transgene lacking introns was
transcribed more efficiently than the normal G allele in TG
mice because of competition for the transcription ma-
chinery and cofactors in cells. This might be the reason why
the normal G allele was downregulated in TG mice and
replaced by the mutant A allele.
It has been shown that NO, a proinflammatory mediator,
is related to the prevalence of osteoarthritis (OA) and
rheumatoid arthritis (RA).21 NO plays roles in various pro-
cesses, including inhibition of ECM biosynthesis, enhance-
ment of ECM degradation, promotion of cellular injury, andpromotion of chondrocyte susceptibility to cytokine-
induced apoptosis, all of which suggest that NO acts as a
catabolic factor.22 NO release was significantly higher in TG
than in WT mice on both Day 1 and Day 14. Furthermore,
soluble GAG production was significantly higher in WT than
in TG mice at all time points. In effect, there is a roughly
inverse relationship between mean NO secretion and mean
soluble GAG production in TG and WT mice, and therefore
we suggest that NO release is related to inhibition of GAG
biosynthesis.
TNF-a and IL-1b are proinflammatory cytokines that
mediate the differentiation of osteoclasts, inducing osteol-
ysis in rheumatoid arthritis, osteolysis in periodontal disease,
and aseptic loosening of prostheses.23 They also induce sy-
novial fibroblasts and articular chondrocytes to produce
proteases that can degrade the cartilagematrix.24 ThemRNA
expression of these proinflammatory cytokines was signifi-
cantly upregulated in TG mice. This parallel upregulation of
TNF-a and IL-1b gene expression in articular cartilage,
together with increased secretion of NO, probably affects
the neighboring subchondral bone. The immune response
caused by diffusion of these proinflammatory cytokines and
mediators might lead to osteolysis of the subchondral bone,
which is relatively hypervascular compared to the covering
cartilage. This proposed process agrees with what is known
about the initial pathological lesions of ONFH and
LeggeCalve´ePerthes disease. These are located in femoral
Col2a1 mutation alters murine phenotype and cartilage matrix homeostasis 811subchondral bone and are highly likely to be related to the
human COL2A1 G1170S mutation. In addition to these
changes, the MTT assay revealed significantly compromised
chondrocyte proliferation in TG mice. This might be a result
of enhanced chondrocyte degeneration due to synergistic
effects of significant TNF-a and IL-1b upregulation and
increased production of NO. Such changes in chondrocyte
degeneration might also be associated with the histological
findings of degeneration-like phenomena in femoral head
cartilage from older TG mice.
Interestingly, MMP-13 mRNA expression by chondrocytes
from TG mice was significantly downregulated relative to
WT mice. Inhibition of this collagen-degrading enzyme
might represent the initiation of a healing process under
the influence of various catabolic factors, such as upregu-
lation of TNF-a and IL-1b expression and increased pro-
duction of NO. However, chondrocyte mRNA expression
levels of MMP-3, MMP-9, ADAMTS-4, and ADAMTS-5 were not
significantly different between TG and WT mice. Articular
cartilage is an avascular connective tissue and the local
immune response induced by upregulation of TNF-a and IL-
1b and increases in NO secretion might not be strong
enough to induce significant ECM degradation. According to
Southern blotting, the copy number for the mutant trans-
gene was only one (data not shown) and the normal Col2a1
gene was still present in TG mice. In such circumstances,
the impact of the mutant gene might not be strong enough
to cause significant alterations in the expression of MMP-3,
MMP-9, ADAMTS-4, and ADAMTS-5 matrix-degrading en-
zymes in TG mice.
The absence of the WT 950-bp fragment in lane 8 of the
genotyping analysis is interesting (Fig. 1). This missing
fragment might result from competition during PCR,
whereby more abundant templates compete with less
abundant ones for reagents. In the PCR amplification step,
the short 371-bp TG template was generated more effi-
ciently than the long 950-bp WT one, resulting in con-
sumption of most the reagents. Consequently, trace
amounts of the 950-bp WT fragment might not be visible on
the agarose gel.
In conclusion, the phenotype of TG mice with the
mutant Col2a1 G1170S gene includes skeletal and chondral
abnormalities, as well as compromised proliferation of
chondrocytes. Furthermore, the mutant A allele acts as a
dominant marker and enhances the gene expression of
various pro-inflammatory factors.
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